Personalizing therapy for older adults with acute myeloid leukemia: Role of geriatric assessment and genetic profiling-Reference-Cited by-同舟云学术

Personalizing therapy for older adults with acute myeloid leukemia: Role of geriatric assessment and genetic profiling

Published:2019-05 Issue: Volume:75 Page:52-61
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Bhatt Vijaya Raj

Funder

National Institute of General Medical Sciences

CTR

National Cancer Institute

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference94 articles.

1. Initial therapy for acute myeloid leukemia in older patients: principles of care;Bhatt;Leuk Lymphoma,2018

2. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia;Klepin;Blood,2013

3. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations;Lindsley;Blood,2015

4. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial;Grimwade;Blood,2001

5. Bhatt VR. Understanding patients’ values and priorities in selecting cancer treatments: Developing a therapy preference scale. J Geriatr Oncol. 2018 [Epub ahead of print].

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies;Current Oncology Reports;2024-09-11

2. Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice;Journal of Personalized Medicine;2023-11-28

3. Personalization in digital health interventions for older adults with cancer: A scoping review;Journal of Geriatric Oncology;2023-11

4. Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia;Journal of Cancer Research and Clinical Oncology;2023-04-15

5. Precision Medicine in Myeloid Malignancies: Hype or Hope?;Current Hematologic Malignancy Reports;2022-08-16